• Rx Redefined

  Participated · Series A · Jan 2023

  Rx Redefined is an Oakland, CA-based health tech company whose platform allows physicians to directly order and fulfill supplies in patients’ best interest, reducing handoffs and improving the patient experience. The company’s platform has enabled physicians to distribute millions of medical products to their patients. In the last year Rx Redefined grew 10x in booked sales and increased its physician population by 450%. Led by CEO Brandon Boots, CTO Erik Smith, and CCO Jayme Hanson, the company focuses on serving group practices with integrated supply services. Rx Redefined plans to use the new funding to invest in sales acceleration, increase operational efficiencies, and expand product features. The description and metrics above are reported by FinSMEs. Rx Redefined is a health‑tech company transforming how physicians prescribe and patients obtain essential medical supplies. The company offers a platform that allows physicians to directly manage the distribution of DMEPOS to their patients. Its stated focus is enabling patients to independently manage their care by simplifying access to needed medical supplies. Rx Redefined was founded in 2018 and is based in Oakland, CA. The company announced the completion of a $2 million seed funding round led by Silverton Partners with participation from Saturn Five.

• Configo Health

  Led · Equity · Apr 2022

  Configo Health is an Asheville, NC–based provider of analytical benchmarking solutions for pediatric hospitals, led by CEO Craig Manson. Its core product is the Opus benchmarking platform, which currently serves Quality & Safety and Diversity, Equity & Inclusion leadership. The company plans to launch a Surgery proposition later in the year. Configo intends to use the $2M funding to bolster customer engagement and development functions. It is expanding operations to serve a forecasted 300% growth in 2022 and maintains offices in Washington D.C., New York City, and Asheville, NC.

• GoCheck

  Led · Equity · Oct 2021

  GoCheck builds GoCheck Kids, a digital vision screening platform used by pediatric teams to prevent vision impairment and blindness in children. The platform is FDA-registered and CE-certified. GoCheck serves 6,500 pediatric teams at hospitals, private practices, schools, and screening organizations across three continents. Led by CEO Kevon Saber, the company focuses on supporting pediatric teams in early detection of vision problems. GoCheck intends to use new funding to grow its team, expand the platform, and deepen customer partnerships. GoCheck Kids offers an iPhone photoscreening app that captures images of children’s eyes and uses proprietary algorithms to detect amblyopia risk factors, delivering immediate results to clinicians. The app is FDA-registered and CE-certified and is used by over 4,500 pediatricians. GoCheck Kids says it reduces screening costs by over 60% versus traditional hardware and bills insurers under CPT codes 99177 and 99174; pricing starts at $149 per month per phone. The company highlights endorsements from the American Academy of Pediatrics, the American Academy of Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Co-founder David Huang, MD, PhD, who co-invented OCT, leads innovation for the product. Future plans include adding AI capabilities using Apple’s CoreML and ARKit and accelerating electronic health record integrations. Gobiquity develops mobile vision screening applications, with its flagship GoCheck Kids combining photoscreening and digital visual acuity in a single app. GoCheck Kids, launched in 2015, is used by more than 2,000 U.S. pediatricians to identify amblyopia risk factors. The company has surpassed 100,000 screenings and now averages over 3,000 children screened per week, representing over 300% annual growth. Gobiquity recently released a new iPhone app for health care providers and plans to extend the product to caregivers and into adult primary care. Management says it is committed to evolving a validated, portable, and affordable mobile screening portfolio to address both children and adults. The company positions its tools as enabling early detection and prevention of vision impairment.

No current team members are available.